Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
34.00
+0.40 (1.19%)
At close: Dec 2, 2025, 4:00 PM EST
34.66
+0.66 (1.94%)
After-hours: Dec 2, 2025, 5:46 PM EST
Indivior Market Cap
Indivior has a market cap or net worth of $4.25 billion as of December 2, 2025. Its market cap has increased by 229.72% in one year.
Market Cap
4.25B
Enterprise Value
4.16B
1-Year Change
229.72%
Ranking
Category
Stock Price
$34.00
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $4.25B, an increase of 177.35%. That is a compound annual growth rate of 9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 4.20B | 170.06% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |